A publication dated August 24, 2026 addresses bivalirudin, titled "Bivalirudin: A Viable Alternative to Heparin for Treatment of Venous Thrombosis in Children?" The article appears in Pediatric Critical Care Medicine, a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. The title frames the publication as an examination of bivalirudin's potential role compared to heparin in treating venous thrombosis in pediatric patients. No specific findings, data, or conclusions from the publication are included in this event record. This brief reports only that the publication exists and its stated title, journal, and date, without summarizing or implying any results. Readers interested in the underlying research should consult the original publication directly for full details. For general background on bivalirudin, its approved status, and other related developments, readers can consult the compound overview.
New Publication Examines Bivalirudin for Pediatric Venous Thrombosis
See the full bivalirudin overview
Source: https://pubmed.ncbi.nlm.nih.gov/42635488/